SCHEMBL14964958

SCHEMBL14964958

CN(C)c1ccc(C=CC=C(C#N)c2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.69
▸ ALDH1A1 P00352 7/20 0.69
▸ RAB9A P51151 6/20 0.69
▸ MAPK1 P28482 2/20 0.69
▸ L3MBTL1 Q9Y468 2/20 0.69
▸ APP P05067 4/20 0.57
▸ NPC1 O15118 5/20 0.53
▸ KMT2A Q03164 6/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ RELA Q04206 1/20 0.51
▸ LMNA P02545 2/20 0.48
▸ MITF O75030 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ SNCA P37840 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14964957 1.00 MAPT (0.69) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL2681040 0.85 MCL1 (0.54) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL4825046 0.85 MCL1 (0.54) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL14965061 0.82 ALDH1A1 (1.00) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL14965059 0.82 ALDH1A1 (1.00) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL6229935 0.81 MAPT (0.72) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL8631910 0.80 RELA (0.59) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL8631913 0.80 RELA (0.59) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL14306901 0.80 MAPT (0.53) MAPTALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL10053864 0.79 APP (0.88) MAPTALDH1A1RAB9AMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072390-A2 STILBENE COMPOUNDS AS PPAR BETA/DELTA INHIBITORS FOR TREATING PPAR BETA/DELTA TRANSMITTED ILLNESSES PHILIPPS-UNIVERSITÄT MARBURG (DE) 2013-05-23 — — WO disclosed
Send feedback